Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patty M Jansen

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Blood|December 4, 2004
Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomasJettie J F Muris, Saskia A G M Cillessen, Wim Vos, et al.
Blood|January 25, 2020
Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous diseaseRutger C Melchers, Rein Willemze, Joost S P Vermaat, et al.
Blood|May 11, 2022
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort studyMirian Brink, Frederik O Meeuwes, Marjolein W M van der Poel, et al.
Blood Advances|May 13, 2024
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer RegistryMirian Brink, Francien Huisman, Frederik O Meeuwes, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2022
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysisFrederik O Meeuwes, Mirian Brink, Marjolein W M van der Poel, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2022
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomasAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Haematologica|October 5, 2023
Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the NetherlandsFrederik O Meeuwes, Mirian Brink, Wouter Plattel, et al.
Virchows Archiv : an International Journal of Pathology|October 18, 2023
Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomasLorraine M de Haan, Ruben A L de Groen, Fleur A de Groot, et al.
Haematologica|May 29, 2025
MATRix and HD-MTX/IFO/DEP treatment and autologous stem cell transplantation in secondary central nervous system lymphoma: a Dutch retrospective analysisFleur A De Groot, Floriske G Stedema, Esther J Kret, et al.
Cancers|October 27, 2022
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease MonitoringAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Blood|December 4, 2004
Immunohistochemical profiling of caspase signaling pathways predicts clinical response to chemotherapy in primary nodal diffuse large B-cell lymphomasJettie J F Muris, Saskia A G M Cillessen, Wim Vos, et al.
Blood|January 25, 2020
Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous diseaseRutger C Melchers, Rein Willemze, Joost S P Vermaat, et al.
Blood|May 11, 2022
Impact of etoposide and ASCT on survival among patients aged <65 years with stage II to IV PTCL: a population-based cohort studyMirian Brink, Frederik O Meeuwes, Marjolein W M van der Poel, et al.
Blood Advances|May 13, 2024
Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer RegistryMirian Brink, Francien Huisman, Frederik O Meeuwes, et al.
European Journal of Cancer (Oxford, England : 1990)|October 8, 2022
Impact of rituximab on treatment outcomes of patients with angioimmunoblastic T-cell lymphoma; a population-based analysisFrederik O Meeuwes, Mirian Brink, Marjolein W M van der Poel, et al.
Virchows Archiv : an International Journal of Pathology|January 14, 2022
Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomasAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Haematologica|October 5, 2023
Outcome of combined modality treatment in first-line for stage I(E) peripheral T-cell lymphoma; a nationwide population-based cohort study from the NetherlandsFrederik O Meeuwes, Mirian Brink, Wouter Plattel, et al.
Virchows Archiv : an International Journal of Pathology|October 18, 2023
Real-world routine diagnostic molecular analysis for TP53 mutational status is recommended over p53 immunohistochemistry in B-cell lymphomasLorraine M de Haan, Ruben A L de Groen, Fleur A de Groot, et al.
Haematologica|May 29, 2025
MATRix and HD-MTX/IFO/DEP treatment and autologous stem cell transplantation in secondary central nervous system lymphoma: a Dutch retrospective analysisFleur A De Groot, Floriske G Stedema, Esther J Kret, et al.
Cancers|October 27, 2022
Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease MonitoringAnne M R Schrader, Ruben A L de Groen, Rein Willemze, et al.
Pageof 6